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Items for this week’s EPI Update include: 
 Antiviral medication for influenza treatment and prophylaxis 
 2018 immunization schedules released 
 Reminder: Mumps testing guidelines 
 Perinatal hepatitis C infection 
 Norovirus outbreak at 2018 Winter Olympics 
 Lassa fever outbreak in Nigeria 
 14 tips for a healthy Valentine’s dinner 
 In the news: Scientists find possible cause for mystery epidemic that 
wiped out Mexico 500 years ago 
 In the news: Black Death spread by humans, vindicating rats 
 Infographic: Lead poisoning is 100% preventable 
 Meeting announcements and training opportunities 
 
Antiviral medication for influenza treatment and prophylaxis 
IDPH has received several questions recently about antiviral medications for 
influenza. CDC updated their antiviral medications summary for clinicians for the 
2017-2018 influenza season. The document highlights indications for influenza 
antiviral medication treatment and prophylaxis. 
 
Antiviral treatment should start as soon as possible for the following: 
 hospitalized patients with suspected or confirmed influenza 
 patients with severe, complicated or progressive influenza illness 
 patients at higher risk for influenza complications, such as those younger 
than 2 or older than 65 years, patients with immunosuppression, residents 
of care facilities, and persons with chronic conditions including pulmonary, 
cardiovascular, and metabolic. 
 
Antiviral prophylaxis is recommended when an influenza outbreak is occurring 
among high risk individuals in an institutional setting, such as a long term care 
facility. An influenza outbreak in a long term care facility is defined as two 
residents with influenza-like illness onset within 72 hours of each other and at 
least one has laboratory confirmed influenza. Reminder: Please call CADE at 
800-362-2736 to report an influenza outbreak. 
 
Antiviral duration and dosage differs between treatment and prophylaxis and may 
vary by situation (e.g., treatment for immunosuppressed patients, prophylaxis for 
residents of a long term care facility, and patients with renal impairment).  
 
For full influenza antiviral guidelines, visit 
www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm.  
2018 immunization schedules released 
The 2018 recommended immunization schedules for children/adolescents and 
adults have been released by the Advisory Committee on Immunization Practices 
(ACIP). 
 
Changes to the schedules include the following:  
 addition of a table outlining vaccine type, abbreviation and brand names 
for vaccines discussed in the child/adolescent immunization schedule 
 updates to the MMR footnote to include guidance regarding the use of a 
third dose of mumps-containing vaccine during a mumps outbreak 
 meningococcal vaccine footnote has been edited to create separate 
footnotes for MenACWY and MenB vaccines 
 updated guidance on the polio vaccine related to children who received 
oral polio as part of their series and catch-up scheduling for 
children/adolescents 4 years and older 
 on the adult schedule, Td/Tdap has been replaced by Tdap or Td and the 
text in the indication bar has been revised to “1 dose Tdap, then Td 
booster every 10 years.” 
 updated recommendations for Zoster vaccines 
 
To view the adult schedule, visit   
www.cdc.gov/vaccines/schedules/hcp/adult.html.  
 
To view the child/adolescent schedule, visit 
www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html.  
 
Reminder: Mumps testing guidelines 
IDPH has received several requests for guidance on mumps testing. Symptoms 
of mumps include swollen salivary glands, respiratory symptoms, sore throat, 
fever and malaise. IDPH recommends testing by both serology for IgM antibodies 
and by RT-PCR using a buccal swab specimen. These tests are more likely to be 
positive at different stages of the disease.  
 
SHL can perform mumps testing. Contact SHL at (319) 335-4500 to request virus 
collection kits, specimen collection instructions, test request forms, and shipping 
instructions or visit www.shl.uiowa.edu/testmenu/clinicaltestmenu.xml and scroll 
to mumps PCR and mumps IgM for forms and detailed collection instructions.  
 
For more information about mumps, visit idph.iowa.gov/CADE/disease-
information/mumps.  
 
 
 
 
 
 
Perinatal hepatitis C infection 
Effective January 1, perinatal hepatitis C virus (HCV) infection became a 
nationally notifiable condition. Increases in perinatal HCV transmission around 
the U.S. have been associated with increased HCV infection among women of 
childbearing age related to the use of opioids. While vertical transmission is 
relatively rare (5 percent), an increase in HCV among women is leading to more 
infected infants. In Iowa, diagnoses of HCV infection among women under the 
age of 40 increased 860 percent from 2000 to 2016, with over 2,100 diagnoses 
during this period. 
 
The typical recommended test to assess HCV infection in infants is HCV RNA 
after at least 2 months of age. Anti-HCV (i.e., antibody) testing should not be 
used in infants under 18 months of age due to transient maternal HCV antibody 
that may not reflect actual infection status of the child. 
 
Currently, there is not a recommendation for universal HCV screening among 
pregnant women. Testing is only recommended for women of childbearing age if 
they are known to be at-risk for HCV infection (i.e., history of injection drug use), 
regardless of pregnancy status. There are no recommended measures currently 
for prevention of HCV transmission by pregnant women to their infants. Available 
curative HCV therapies are not currently recommended for pediatric patients 
under the age of 12. 
 
Questions regarding reporting of infants or pregnant women with HCV infection 
may be directed to Shane Scharer at shane.scharer@idph.iowa.gov or (515) 
657-1129. 
 
To view a CDC press release about the increase in HCV linked to opioids, visit 
www.cdc.gov/nchhstp/newsroom/2017/hepatitis-c-and-opioid-injection-press-
release.html.  
 
The perinatal hepatitis C case definition can be found at 
wwwn.cdc.gov/nndss/conditions/hepatitis-c-perinatal-infection/case-
definition/2018/.  
 
Norovirus outbreak at 2018 Winter Olympics 
Several media outlets have reported a large norovirus outbreak occurring in and 
around sites for the 2018 Winter Olympics in South Korea. Iowa has also 
investigated smaller norovirus outbreaks in the last several weeks. Norovirus 
cases tend to peak in winter, and the virus is easily spread from person to 
person. Norovirus is not a reportable disease in Iowa, but all suspected 
outbreaks are reportable. Those ill with vomiting and/or diarrhea should stay 
home while sick, wash their hands frequently, and avoid making food for others 
for 48 hours after symptoms have resolved.  
 
For more information on norovirus, visit www.cdc.gov/norovirus/index.html.  
Lassa fever outbreak in Nigeria 
According to several media reports, dozens of people have died as part of an 
ongoing outbreak of Lassa fever in Nigeria. The disease is endemic to West 
Africa, and the reservoir of the virus is a rat species that often lives in and around 
human settlements.  
 
Many who are infected show mild, non-specific symptoms and may not be 
diagnosed. However, about 20 percent of patients develop serious symptoms 
that include hemorrhaging, respiratory distress, and shock. The overall case 
fatality rate is around 1 percent, but 15-20 percent of hospitalized patients die.  
 
Viral hemorrhagic fever, including Lassa fever, is immediately reportable in Iowa. 
If you suspect a patient has viral hemorrhagic fever, please contact CADE 
immediately at 800-362-2736. 
 
For more information about Lassa fever, visit www.cdc.gov/vhf/lassa/index.html.  
 
14 tips for a healthy Valentine’s dinner 
CDC has released some tips, just in time for Valentine’s Day.  
 
See them at www.cdc.gov/features/valentinesdinner/.  
 
In the news: Scientists find possible cause for mystery epidemic that wiped 
out Mexico 500 years ago 
www.washingtonpost.com/news/morning-mix/wp/2018/01/16/scientists-find-
possible-cause-for-mystery-epidemic-that-wiped-out-mexico-500-years-
ago/?utm_term=.75511a2ff527  
 
In the news: Black Death spread by humans, vindicating rats 
www.cnn.com/2018/01/16/health/black-death-plague-spread-by-humans-
intl/index.html  
 
Infographic: Lead poisoning is 100% preventable 
 
 
To view in full size, visit 
pht.idph.state.ia.us/Health/LeadPoisoning/Documents/Lead%20Program%20Info
rmation%20Cards%20Sheet_Prevention.pdf.  
 
Meeting announcements and training opportunities 
The 2018 Iowa Governor’s Conference on Public Health will be held April 10 and 
11 at the Holiday Inn Des Moines Airport. To view the brochure, visit 
www.iowapha.org/resources/Documents/2018%20IGCPH%20Conference%20Br
ochure.pdf. 
 
Have a healthy and happy week! 
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